Tumors with ALK rearrangements can harbor more mutations

April 25, 2013

The identification of potentially targetable kinase mutations has been an exciting advancement in lung cancer treatment. Although the mutations driving many lung carcinomas remain unknown, approximately 50% of lung adenocarcinoma cases harbor KRAS mutation, EGFR mutation, or ALK translocation, and an additional 5% have been shown to have mutations involving BRAF, PIK3CA, HER2, MET, MEK1, NRAS, and AKT. In the vast majority, these driver mutations are mutually exclusive. But in a recent study published in the Journal of Thoracic Oncology researchers found that tumors with ALK rearrangements can harbor additional mutations.

Researchers looked at 25 cases of pulmonary adenocarcinoma surgically treated at Mayo Clinic between 1999 and 2007 with ALK gene rearrangement, confirmed by break-apart fluorescent in situ hybridization (FISH) and immunohistochemistry (IHC). Using the DNA extracted from formalin-fixed paraffin-embedded tumor samples, a MassArray-based Lung Cancer Mutations Screening Panel was performed to test for 179 individual mutations in 10 genes, with positive results confirmed by sequencing.

They found additional mutations in five of 25 ALK positive cases. Four of these were point mutation in the MET gene that are of unknown clinical significance, since they may represent germline polymorphisms. However, one case had an EGFR mutation, further supporting that EGFR mutations can be present in ALK rearranged tumors, although it is rare.

Further research is needed to determine if patients with coexisting EGFR mutation and ALK gene rearrangement may have altered response to EGFR or ALK inhibitors. This will help determine whether these drugs should be used in a synchronous or sequential fashion for maximum benefit. Read the study abstract.

Sponsored Recommendations

The Race to Replace POTS Lines: Keeping Your People and Facilities Safe

Don't wait until it's too late—join our webinar to learn how healthcare organizations are racing to replace obsolete POTS lines, ensuring compliance, reducing liability, and maintaining...

Transform Care Team Operations & Enhance Patient Care

Discover how to overcome key challenges and enhance patient care in our upcoming webinar on September 26. Learn how innovative technologies and strategies can transform care team...

Prior Authorization in Healthcare: Why Now?

Prepare your organization for the CMS 2027 mandate on prior authorization via API. Join our webinar to explore investment insights, real-time data exchange, and the benefits of...

Securing Remote Radiology with the Zero Trust Exchange

Discover how the Zero Trust Exchange is transforming remote radiology security. This video delves into innovative solutions that protect sensitive patient data, ensuring robust...